Kelzyn

Dienogest, the active ingredient in Kelzyn, is a combined oral contraceptive presented as a tablet for oral use. Together with ethinylestradiol, it provides hormonal regulation that prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Kelzyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets, and meeting the needs of diverse healthcare providers. The product is manufactured under strict GMP standards and distributed to multiple regions.

Kelzyn, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy. - Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus. - Menstrual cycle regulation: helps achieve more regular menstrual cycles. - Dysmenorrhea management: reduces menstrual pain and cramps.

Kelzyn may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset. - Headache: tension or migraine‑type pain. - Breast tenderness: swelling or discomfort. - Irregular bleeding: spotting or breakthrough bleeding. - Weight gain: mild increase in body weight. - Mood changes: irritability or emotional fluctuations.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins. - Pulmonary embolism: clot traveling to lungs. - Stroke: cerebrovascular accident. - Myocardial infarction: heart attack. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Kelzyn, consider the following precautions to ensure safe use. - Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk. - Cardiovascular disease: contraindicated in patients with history of thromboembolic disorders. - Hypertension: monitor blood pressure regularly. - Liver disease: use with caution in hepatic impairment. - Migraine with aura: avoid due to heightened stroke risk. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Kelzyn can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Anticoagulants: may reduce effectiveness of warfarin, increasing clot risk. - Enzyme inducers (e.g., rifampicin, carbamazepine): can lower hormone levels, reducing contraceptive reliability. - Certain antiretrovirals (e.g., protease inhibitors): may increase hormone concentrations, raising side‑effect risk.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): may increase plasma levels of ethinylestradiol. - Antidepressants (e.g., SSRIs): may affect bleeding patterns. - Herbal supplements (e.g., St. John’s wort): may modestly reduce contraceptive effectiveness.